RC220 Phase 1a/b trial - 12-18 months.
Cardioprotection & m6A RNA phase 2 trial - 18-24 months.
The plan strategy hasn't changed. 4+ years away.
Stop the DT retiring after P1 narrative.
Race Buyout vs. Licensing, page-2
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.59 |
Change
-0.025(1.55%) |
Mkt cap ! $264.5M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.60 | $1.55 | $66.44K | 42.34K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14287 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.58 | 13999 | 1 |
View Market Depth
| Last trade - 13.21pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.56 |
Change
-0.025 ( 1.17 %) |
||||
| Open | High | Low | Volume | ||
| $1.58 | $1.59 | $1.55 | 7324 | ||
| Last updated 13.37pm 16/05/2024 ? | |||||
| RAC (ASX) Chart |